RxSight, Inc. (NASDAQ: RXST) reported Q4 EPS of $0.03, $0.20 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $40.2 million versus the consensus estimate of $40.39 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.